141 related articles for article (PubMed ID: 3315317)
61. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF
Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173
[No Abstract] [Full Text] [Related]
62. Hematologic malignancies in pregnancy.
Hurley TJ; McKinnell JV; Irani MS
Obstet Gynecol Clin North Am; 2005 Dec; 32(4):595-614. PubMed ID: 16310674
[TBL] [Abstract][Full Text] [Related]
63. CD200 in High-Grade Lymphoma, Chronic Lymphocytic Leukemia, and Chronic Lymphocytic Leukemia-Phenotype Monoclonal B-Cell Lymphocytosis.
Sorigue M; Junca J; Granada I
Am J Clin Pathol; 2015 Oct; 144(4):677-9. PubMed ID: 26386092
[No Abstract] [Full Text] [Related]
64. The contribution of immunologic methods to the classification of leukemias and malignant lymphomas.
Plesner T; Wilken M; Avnstrøm S
Clin Lab Med; 1982 Sep; 2(3):579-97. PubMed ID: 6754227
[No Abstract] [Full Text] [Related]
65. Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma.
Kung PC; Long JC; McCaffrey RP; Ratliff RL; Harrison TA; Baltimore D
Am J Med; 1978 May; 64(5):788-94. PubMed ID: 347933
[TBL] [Abstract][Full Text] [Related]
66. Application of monoclonal antibodies in the management of hematologic malignancies: the state of the art and future directions.
Dasgupta A
Indian J Cancer; 1985 Mar; 22(1):59-67. PubMed ID: 3915493
[No Abstract] [Full Text] [Related]
67. [Genotype study of T receptors in the diagnosis and classification of leukemias and lymphomas].
Soler J; Baiget M; Rubiol E; Guañabens C; Nunes V; Estivill X; Bosch MA
Med Clin (Barc); 1988 Jun; 91(4):135-8. PubMed ID: 3262799
[No Abstract] [Full Text] [Related]
68. [Urinary polyamine analysis and its clinical significance. II. Analysis by enzymatic assay method and its clinical application. I. Urinary polyamines in patients with hematologic malignancies].
Nagoshi H; Shiraishi M
Rinsho Byori; 1984 Jul; Spec No 59():123-30. PubMed ID: 6502961
[No Abstract] [Full Text] [Related]
69. [Blood serum polyamines and their urinary excretion in malignant lymphoma].
Draga NV; Berdinskikh NK; Kindzel'skiĭ LP; Zaletok SP; Usatenko VD
Vrach Delo; 1983 Dec; (12):44-6. PubMed ID: 6670234
[No Abstract] [Full Text] [Related]
70. Leukaemia 'firsts' in cancer research and treatment.
Greaves M
Nat Rev Cancer; 2016 Mar; 16(3):163-72. PubMed ID: 26911190
[TBL] [Abstract][Full Text] [Related]
71. [Significance and future directions of the pathological classification of malignant lymphoma].
Mori S
Rinsho Ketsueki; 2003 Apr; 44(4):202-4. PubMed ID: 12784651
[No Abstract] [Full Text] [Related]
72. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
73. [Leukemia and malignant tumors].
Kuramoto A
Nihon Naika Gakkai Zasshi; 1991 Mar; 80(3):467-72. PubMed ID: 1856568
[No Abstract] [Full Text] [Related]
74. Neurologic Complications of Lymphoma, Leukemia, and Paraproteinemias.
Mauermann ML
Continuum (Minneap Minn); 2017 Jun; 23(3, Neurology of Systemic Disease):669-690. PubMed ID: 28570324
[TBL] [Abstract][Full Text] [Related]
75. Erythrocyte pyruvate kinase activity during chemotherapy in children with leukemia and lymphoma.
Yilmaz HL; Tanyeli A; Ozüsaglam H; Kayrin L; Antmen B; Sasmaz HI
Bratisl Lek Listy; 2002; 103(7-8):238-43. PubMed ID: 12518995
[TBL] [Abstract][Full Text] [Related]
76. Comparison of phenotyping and genotyping of lymphoid neoplasms.
Sun T; Eisenberg A; Benn P; Ngu M; Guarino T; Henshall J; Grossman A; Cuomo J; Vinciguerra V
J Clin Lab Anal; 1989; 3(3):156-62. PubMed ID: 2754532
[TBL] [Abstract][Full Text] [Related]
77. [Clinical use of polymerase chain reaction in diagnosis and monitoring of malignant diseases].
Jäger U; Laczika K; Scholten C; Mitterbauer M; Novak M; Lechner K
Wien Klin Wochenschr; 1996; 108(20):634-9. PubMed ID: 9005678
[TBL] [Abstract][Full Text] [Related]
78. The proposed revised European-American classification of lymphoma.
Lister TA; Norton AJ; Rohatiner A
Blood; 1995 Apr; 85(7):1975. PubMed ID: 7703502
[No Abstract] [Full Text] [Related]
79. Highlights from the 2023 American Society of Clinical Oncology Annual Meeting: leukemia and lymphoma.
O'Brien S
Clin Adv Hematol Oncol; 2023 Jul; 21(7):359-361. PubMed ID: 37477994
[No Abstract] [Full Text] [Related]
80. [Preliminary analysis of the Polish lymphoma register: usefulness of the Kiel classification for clinical characteristics and evaluation of therapeutic results].
Mioduszewska O; Woźniak L; Hyjek E; Krykowski E; Musiatowicz B; Ostrowski L; Polkowska-Kulesza K; Porwit-Ksiazek A; Sochacka B; Szadowska A; Walewski J
Nowotwory; 1980; 30(2):109-17. PubMed ID: 7413444
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
